Theravance Biopharma, Inc. (TBPH)

NASDAQ: TBPH · Real-Time Price · USD

16.23

+0.97 (6.36%)

At close: Mar 31, 2026, 4:00 PM EDT

15.91

-0.32 (-1.97%)

After-hours: Mar 31, 2026, 4:16 PM EDT

Theravance Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	167.81	37.8	39.55	298.17	89.96
Short-Term Investments	147.55	50.55	62.88	29.31	83.51
Cash & Short-Term Investments	315.36	88.35	102.43	327.48	173.47
Cash Growth	256.94%	-13.74%	-68.72%	88.79%	-40.78%
Accounts Receivable	95.54	68.44	17.47	16.79	14.07
Other Receivables	-	-	-	-	43.53
Total Trade Receivables	95.54	68.44	17.47	16.79	57.6
Other Current Assets	7.56	4.28	13.64	9.2	18.81
Total Current Assets	418.46	161.07	133.54	353.46	249.87
Net Property, Plant & Equipment	30.27	35.77	45.36	52	53.35
Long-Term Investments	11.13	-	-	-	67.54
Other Long-Term Assets	25.72	157.32	203.1	201.94	4.07
Total Assets	485.57	354.16	382	607.4	374.82
Accounts Payable	2.57	2.24	1.52	1.55	3.1
Accrued Expenses	18.02	11.06	11.59	19.27	36.64
Current Portion of Long-Term Debt	-	-	-	-	16.94
Current Portion of Leases	10.95	10.71	3.92	6.75	0.5
Unearned Revenue	-	-	-	-	0.1
Other Current Liabilities	6.77	8.07	7.73	1.14	1.3
Total Current Liabilities	38.3	32.09	24.77	28.72	58.59
Long-Term Debt	-	-	-	-	599.39
Long-Term Leases	31.76	39.11	45.24	45.41	52.68
Other Long-Term Liabilities	118.79	107.42	99	91.48	2.73
Total Long-Term Liabilities	150.55	146.53	144.24	136.89	654.81
Total Liabilities	188.85	178.62	169	165.6	713.39
Common Stock	0	-	-	0	0
Additional Paid-in Capital	1,156	1,141	1,122	1,296	1,387
Accumulated Other Comprehensive Income	0.06	0.01	-0.07	-0.02	-
Retained Earnings	-859.63	-965.52	-909.1	-853.91	-1,726
Shareholders' Equity	296.72	175.55	213	441.8	-338.57
Total Liabilities & Equity	485.57	354.16	382	607.4	374.82
Total Debt	42.7	49.82	49.16	52.16	669.52
Net Cash (Debt)	272.65	38.53	53.27	275.32	-496.05
Net Cash Growth	607.64%	-27.67%	-80.65%	-	-
Net Cash Per Share	5.29	0.79	0.96	3.74	-7.14
Book Value	296.72	175.55	213	441.8	-338.57
Book Value Per Share	5.76	3.59	3.85	6.00	-4.87
Tangible Book Value	296.72	175.55	213	441.8	-338.57
Tangible Book Value Per Share	5.76	3.59	3.85	6.00	-4.87

Updated Mar 19, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q